BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 253 filers reported holding BIONTECH SE in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,571,761 | +15.2% | 226,176 | +14.5% | 0.03% | +18.2% |
| Q2 2023 | $21,326,968 | +374.4% | 197,600 | +447.6% | 0.02% | +340.0% |
| Q1 2023 | $4,495,358 | -85.7% | 36,087 | -82.7% | 0.01% | -85.3% |
| Q4 2022 | $31,423,470 | -6.9% | 209,183 | -16.4% | 0.03% | -17.1% |
| Q3 2022 | $33,762,000 | -56.3% | 250,315 | -51.6% | 0.04% | -54.4% |
| Q2 2022 | $77,189,000 | -50.2% | 517,693 | -43.0% | 0.09% | -37.9% |
| Q1 2022 | $154,899,000 | -14.6% | 908,178 | +29.1% | 0.14% | -4.0% |
| Q4 2021 | $181,335,000 | +19.7% | 703,394 | +26.8% | 0.15% | +9.4% |
| Q3 2021 | $151,438,000 | +232.5% | 554,739 | +172.7% | 0.14% | +245.0% |
| Q2 2021 | $45,548,000 | +1315.9% | 203,446 | +590.6% | 0.04% | +1233.3% |
| Q1 2021 | $3,217,000 | -29.4% | 29,459 | -47.3% | 0.00% | -25.0% |
| Q4 2020 | $4,557,000 | – | 55,898 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |